In particular, THR- activation is linked to important metabolic benefits in the liver, as it can reduce cholesterol and triglyceride levels, stimulate bile acid synthesis, and promote fat oxidation
In October 2021, the drug manufacturer submitted a marketing authorisation application to the EMA and a priority review voucher to the US FDA for the regulatory approval of tirzepatide in type 2 diabetes, leading to an expected review time of 8 months from the date of submission [12]
Mild and uncommon
If shedding starts at months three to six, it is almost certainly telogen effluvium and it will resolve
Balancing the potential benefits and risks of any medication during pregnancy is crucial for the health and safety of both the mother and the developing baby
People taking Semaglutide can expect greater improvements in cardiovascular risk factors like BMI (body-mass index), waist circumference, and blood pressure in addition to improved sugar metabolism